Overview
Right ventricular hypertension (RVH) refers to elevated pressure in the right ventricle, often secondary to conditions like pulmonary hypertension or chronic lung diseases. It can complicate management in patients with coexisting cardiovascular and respiratory conditions, particularly hypertension and diabetes.Diagnosis
Clinical Symptoms: Dyspnea, fatigue, peripheral edema 2.
Diagnostic Tests: Echocardiography for initial assessment, right heart catheterization for definitive diagnosis 2.
Laboratory Tests: Elevated natriuretic peptides may indicate right heart strain 2.
Co-morbid Conditions: Hypertension and diabetes are common comorbidities that may contribute to RVH 134.Management
First-line Treatments:
- Pulmonary Hypertension-Specific Therapy: If RVH is secondary to pulmonary hypertension, consider endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostacyclin analogs 2.
- Blood Pressure Control: Optimize antihypertensive therapy to manage systemic hypertension, favoring ACE inhibitors or ARBs 24.
Adjunctive Treatments:
- Diabetes Management: Intensive glycemic control with metformin, insulin, or other antidiabetic agents as needed 24.
- Lifestyle Modifications: Encourage smoking cessation, exercise, and dietary modifications 2.Special Populations
Elderly: Polypharmacy is prevalent, impacting adherence; careful medication review and simplification recommended 13.
Comorbidities: Patients with both hypertension and diabetes require meticulous management to avoid regimen complexity leading to nonadherence 134.Key Recommendations
Implement three-dimensional team management to enhance diagnostic and treatment capabilities for patients with hypertension and diabetes, improving overall control 2 (Evidence: Moderate).
Simplify medication regimens in elderly patients to improve adherence, especially in those with polypharmacy 1 (Evidence: Strong).
Regularly monitor and optimize blood pressure and glycemic control in patients with RVH to mitigate disease progression 24 (Evidence: Moderate).References
1 Alharby TN, Alanazi M, Khan KU, Ansari M, Alwqdan G, Almansour H et al.. Polypharmacy among Saudi seniors in Hail region: A cross-sectional study on prevalence and association with medication adherence. Medicine 2026. link
2 Lu X, Tang H, Xu T, Song X, Jiang F, Zheng X et al.. The Significance of Three-Dimensional Team Management in the Medical Community Model for Patients with Hypertension and Diabetes. Journal of healthcare engineering 2022. link
3 Franchini M, Pieroni S, Fortunato L, Molinaro S, Liebman M. Poly-pharmacy among the elderly: analyzing the co-morbidity of hypertension and diabetes. Current pharmaceutical design 2015. link
4 Rettig SM, Wood Y, Hirsch JD. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes. Journal of the American Pharmacists Association : JAPhA 2013. link
5 Nshisso LD, Reese A, Gelaye B, Lemma S, Berhane Y, Williams MA. Prevalence of hypertension and diabetes among Ethiopian adults. Diabetes & metabolic syndrome 2012. link